Mettler-Toledo International Inc. (NYSE:MTD) – Equities research analysts at Jefferies Group raised their Q2 2017 EPS estimates for shares of Mettler-Toledo International in a research note issued to investors on Monday. Jefferies Group analyst B. Couillard now expects that the medical instruments supplier will post earnings of $3.89 per share for the quarter, up from their previous estimate of $3.56. Jefferies Group also issued estimates for Mettler-Toledo International’s Q4 2017 earnings at $5.76 EPS, FY2017 earnings at $17.10 EPS, Q3 2018 earnings at $4.81 EPS, FY2018 earnings at $19.10 EPS and FY2019 earnings at $21.00 EPS.
A number of other analysts also recently issued reports on MTD. Deutsche Bank AG reaffirmed a “hold” rating and set a $420.00 price target on shares of Mettler-Toledo International in a report on Wednesday, January 18th. Zacks Investment Research raised Mettler-Toledo International from a “sell” rating to a “hold” rating and set a $522.00 price target for the company in a report on Tuesday, February 7th. Finally, Cleveland Research raised Mettler-Toledo International from a “neutral” rating to a “buy” rating in a report on Wednesday, April 19th. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $445.60.
Mettler-Toledo International (NYSE:MTD) opened at 547.43 on Wednesday. The firm has a market capitalization of $14.14 billion, a price-to-earnings ratio of 35.72 and a beta of 1.14. Mettler-Toledo International has a 12 month low of $343.61 and a 12 month high of $566.49. The company’s 50-day moving average price is $491.99 and its 200 day moving average price is $450.08.
Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, May 4th. The medical instruments supplier reported $3.34 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $3.08 by $0.26. Mettler-Toledo International had a return on equity of 81.17% and a net margin of 15.32%. The company had revenue of $594.57 million for the quarter, compared to analyst estimates of $571.30 million. During the same period in the prior year, the company posted $2.46 EPS. The firm’s quarterly revenue was up 10.2% compared to the same quarter last year.
In other news, insider Simon Kirk sold 218 shares of the business’s stock in a transaction dated Thursday, March 9th. The stock was sold at an average price of $484.00, for a total value of $105,512.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider William P. Donnelly sold 4,830 shares of the business’s stock in a transaction dated Thursday, February 9th. The shares were sold at an average price of $466.47, for a total value of $2,253,050.10. Following the completion of the sale, the insider now directly owns 2,000 shares of the company’s stock, valued at $932,940. The disclosure for this sale can be found here. Insiders sold a total of 20,048 shares of company stock valued at $9,323,062 over the last three months. Company insiders own 5.60% of the company’s stock.
Hedge funds have recently bought and sold shares of the stock. FMR LLC increased its stake in Mettler-Toledo International by 3.5% in the fourth quarter. FMR LLC now owns 2,755,694 shares of the medical instruments supplier’s stock valued at $1,153,423,000 after buying an additional 93,274 shares during the last quarter. State Street Corp increased its stake in Mettler-Toledo International by 3.2% in the fourth quarter. State Street Corp now owns 1,128,261 shares of the medical instruments supplier’s stock valued at $472,252,000 after buying an additional 35,043 shares during the last quarter. Fiera Capital Corp increased its stake in Mettler-Toledo International by 7.1% in the fourth quarter. Fiera Capital Corp now owns 547,460 shares of the medical instruments supplier’s stock valued at $229,144,000 after buying an additional 36,056 shares during the last quarter. Bank of New York Mellon Corp increased its stake in Mettler-Toledo International by 13.7% in the first quarter. Bank of New York Mellon Corp now owns 390,609 shares of the medical instruments supplier’s stock valued at $187,067,000 after buying an additional 47,179 shares during the last quarter. Finally, Russell Investments Group Ltd. bought a new position in shares of Mettler-Toledo International during the fourth quarter valued at about $126,577,000. 96.91% of the stock is owned by institutional investors and hedge funds.
Mettler-Toledo International Company Profile
Mettler-Toledo International Inc is a supplier of precision instruments and services. The Company operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. The Company manufactures weighing instruments for use in laboratory, industrial, packaging, logistics and food retailing applications.
Receive News & Ratings for Mettler-Toledo International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.